Empowering Scientists for the Benefit of Human Health

The Leader in Cell Line Development

Selexis is the global leader in mammalian cell line development that leverages best-in-class protein expression technologies and modular workflows to create highly specialized solutions that enable the bio-pharmaceutical industry to streamline the drug discovery through development continuum and rapidly commercialize innovative biologic-based medicines and vaccines against diseases of high unmet need such as cancer, autoimmune and inflammatory diseases, infectious diseases, blood, metabolic and genetic disorders as well as dermatology and ophthalmic diseases.

Connect with us. From ubiquitous immunoglobulin-based drugs such as monoclonal and multispecific antibodies and Fc Fusions to novel scaffolds and difficult-to-express proteins, Selexis is your partner of choice.